More China Infant Deaths; Vaccine Producers Fail to Get GMP Certification

Chinese Health Authorities have reported two additional infant deaths, following Hep B vaccines from the Dalian Hissen Bio-Pharm Inc.

This brings the infant death total to 11, with three different vaccine producers - Kangtai Biological Products, Beijing Tiantan Biological Products, and Dalian Hissen Bio-Pharm - implicated in the investigation.

According to the Global Times, the China Food and Drug Administration did not include the three aforementioned companies on its most updated list of companies that have received the Good Manufacturing Practices certificate for pharmaceutical products. This means that China's top three producers of hepatitis B vaccines are banned from manufacturing new products in 2014, which may cause a shortage in the market.

 

More News:

All news »

What are your comments?

You cannot post comments until you have logged in. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments